NAFDAC receives four dossiers of Covid-19 vaccines for evaluation
The Minister of Health, Osagie Ehanire, says the National Agency for Food and Drug Administration and Control, NAFDAC has received the dossiers of four different Covid-19 vaccines for evaluation ahead of their usage..
Ehanire disclosed this at the weekly press briefing of the Presidential Task Force on Covid-19 in Abuja.
He said the results of some of the evaluations were almost ready.
The Minister said since all Covid-19 vaccines were carrying a certain amount of risk, any vaccine not approved by the Ministry of Health through its agencies would not be used in Nigeria.
Ehanire said, “The National Agency for Food and Drug Administration and Control has received dossiers for Sputnik V vaccine of Russia, Covishield or Astra Zeneca manufactured under licence by Serum Institute of India, Covaxin by Bharat vaccines of India and the Sinopharm Vaccine of China, for evaluation and validation for use in Nigeria. Some of them are nearly ready for results.
“It is important to stress that all COVID-19 vaccines carry a certain amount of risk and any vaccines not approved by the Federal Ministry of Health through its agencies cannot be used in Nigeria. The government will not be responsible for the safety or efficacy of vaccines given outside the framework of the government.
“All the needs of Nigeria have been carefully calculated by the National Primary Health Care Development Agency and it is possible to accommodate all interests in the framework.”
Ehanire said his ministry engaged The Africa Vaccine Acquisition Task Team who he said informed the government of the free allocation of 1.4 million doses of AstraZeneca vaccines, of which 500,000 doses are expected by the end of February.
He stated that the balance of 900,000 doses for Nigeria was expected by the end of March 2021 while other sources of vaccines are under negotiation.
“I received a message from the High Commissioner of India, giving 100,000 AstraZeneca or Covishield vaccine doses, also by the Serum Institute of India, as a gift of the Government of India to Nigeria. These gestures of goodwill and partnership are appreciated by the people of Nigeria.
“With regard to the African Vaccine Acquisition Task Team, Nigeria has completed her account opening, signed by two officials each, of the Ministry of Health and the Ministry of Finance, Budget & National Planning, at Afrexim Bank as a requirement for access to vaccines on that platform, which will give Nigeria access to a much larger portfolio and variety of vaccines.
“Among the vaccines are the Johnson & Johnson single dose vaccine and as much of the Pfizer mRNA vaccines as we can manage. The COVID-19 Vaccine Coordinating Committee and NPHCDA’s strategy for vaccine delivery will advise the mix of vaccines that Nigeria will acquire,” the minister explained.
Ehanire said the PTF was beginning to observe “what may cautiously be said to be a decline in the rate of spread of Covid-19 infection in this second wave.”
NP/Confidence Okwuchi
